title How New Jersey tamped down PFAS in drinking water

description Nearly all Americans have some type of PFAS, commonly known as “forever chemicals,” in their blood. The chemicals, which are linked to numerous health issues, were first regulated in drinking water at the federal level two years ago (though some limits have been rolled back).

But, back in 2018, New Jersey became the first state to adopt its own drinking water standards for PFAS. Now, researchers at Rutgers University have crunched the data to see how well it worked. They found that levels of the regulated chemicals dropped by as much as 55%. 

Host Ira Flatow talks with the lead author of the study, cancer epidemiologist Hari Iyer about the significance of his findings and his plans to study the possible link between PFAS and prostate cancer.

Want to filter PFAS from your tap at home? Learn more:


Identifying Drinking Water Filters Certified to Reduce PFAS via EPA
Home Water Treatment for PFAS via PennState Extension

Guest: 

Dr. Hari Iyer is an assistant professor of cancer epidemiology and health outcomes at the Rutgers Cancer Institute of New Jersey. 

Transcripts for each episode are available within 1-3 days at sciencefriday.com.

Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

pubDate Mon, 20 Apr 2026 10:00:00 GMT

author ira flatow, Shoshannah Buxbaum, Hari Iyer

duration 739000

transcript

Speaker 1:
[00:00] WNYC Studios is supported by Odoo. When you buy business software from lots of vendors, the costs add up and it gets complicated and confusing. Odoo solves this. It's a single company that sells a suite of enterprise apps that handles everything from accounting to inventory to sales. Odoo is all connected on a single platform in a simple and affordable way. You can save money without missing out on the features you need. Check out Odoo at odoo.com. That's odoo.com.

Speaker 2:
[00:33] Hi, this is Ira Flatow and you're listening to Science Friday. Nearly every one of us has some type of PFAS, commonly known as Forever Chemicals, in their blood. These chemicals are found in non-stick pan coatings, waterproof materials and firefighting foam. Roughly two years ago, the EPA adopted federal regulations for PFAS levels in drinking water, though last year the Trump administration rolled back some of those regulations. But back in 2018, New Jersey was the first state to adopt its own drinking water standards for PFAS. Now 10 years later, researchers at Rutgers University have crunched the data to see how well it worked. Joining me now to tell us more is the lead author of the study, Dr. Hari Iyer, Assistant Professor of Cancer Epidemiology and Health Outcomes at the Rutgers Cancer Institute of New Jersey, based in New Brunswick, New Jersey. Welcome to Science Friday.

Speaker 3:
[01:34] Thanks so much, Ira. It's so great to be here.

Speaker 2:
[01:37] Nice to have you. Okay, let's jump right in. What did you find in this study?

Speaker 3:
[01:43] We're so excited to present these results of a evaluation of state policies to reduce PFAS levels in drinking water, and we found a 55% reduction in average concentrations after the policy was implemented.

Speaker 2:
[01:57] Wow. Is that a surprising study? I mean, that's pretty big drop.

Speaker 3:
[02:01] So it's interesting you asked that. Our government colleagues were not surprised. They said, you know, Hari, we know when we put these policies in place, we expect to see a drop. That's why we do them. But I think we were excited to see this because in public health, often our message is, you know, this thing is bad for you. This disease is becoming more prevalent. But here we were actually able to demonstrate a positive impact of a regulation.

Speaker 2:
[02:32] So would you describe the PFAS in the water now at a safe level in New Jersey?

Speaker 3:
[02:39] So we definitely have observed levels that are below the maximum contaminant levels they're called, these regulatory limits. But I think that there's another part of this story, which is the ongoing evolution of our understanding of the health impacts of long-term exposure. So something that a lot of folks will ask is, that's great that the water levels have dropped today, but have I been drinking water for the last 20 years that has had higher levels? If so, how does this help me? And I think that that's a very fair question to ask. And so I think when you ask the question about safe levels, I think we're still kind of understanding these long-term health risks.

Speaker 2:
[03:25] Yeah, so we don't know what those long-term health risks are. Do we know what portion of our daily ingestion of PFAS comes from drinking water?

Speaker 3:
[03:36] So that's a complicated question. It's a good one. But what I will say is based on a lot of this accumulating evidence from animal studies and from toxicology studies and cells, what has been shown is that once water is ingested into the body, the concentration in the water can be magnified by orders of magnitude. And so while I don't know if I have a precise answer of what contribution water is, it is certainly a very important one. Because of this biological magnification effect, it's still a major area that we want to control.

Speaker 2:
[04:17] Yeah, I want to dig into that more. So what happens when you drink the PFAS in it? How does your body, as you say, magnify what's going on?

Speaker 3:
[04:26] That's a great question. I can speak a bit more to the health side than the consumption side. So on the health side, I think what has started to become more evident is that the water passes through your body and usually gets filtered in the kidney and liver. Those are the organs where some of the best established emerging evidence on a health impact seems to be. So kidney function and risk of certain kidney cancers have been linked to these PFAS exposures. A lot of liver enzyme levels that sometimes you get monitored at the doctor's office, those seem to be elevated in people who have high consumption of these chemicals. And so some of what we're doing at the Cancer Institute and other places is now trying to understand those elevated levels. Are they being linked now to these downstream cancer outcomes and other chronic disease outcomes?

Speaker 2:
[05:19] How did New Jersey limit the PFAS? Did they have special treatment plants or filters?

Speaker 3:
[05:25] I'm glad you asked that question because it turns out that there were a lot of actions that we observed when we were reviewing these data. Actions taken by water systems in anticipation of the policies coming into place. Some examples of some of those actions are identifying wells that have really excess levels and then just pulling them offline. So they're no longer going to be serving people at their home. Another example is like what you had just asked about, which are granulated activated carbon. It allows us to kind of identify these PFAS chemicals, catch them and remove them from the water. So post-treatment, those levels are no longer as high.

Speaker 2:
[06:05] When you said well water, were you talking about people's individual well water? They were able to eliminate the PFAS from that?

Speaker 3:
[06:13] So no. In this context, what I was referring to is that often water that is provided from different systems, they will have their own wells that are sources of water that then gets transferred. Unfortunately, one of the limitations of our study is that it was really only looking at public water systems. And so unfortunately, we're not able to demonstrate that this 55% reduction holds in people's home well systems, because those don't tend to be tested as often. And that's about 1 in 10 New Jersey residents, I believe, is served by their home well.

Speaker 2:
[06:49] So is New Jersey's water more contaminated than other states?

Speaker 3:
[06:53] So unfortunately, there's been nationwide studies that have looked at levels over the past 15 years or so. And yes, unfortunately, New Jersey has in the past had higher levels on average than other states. However, given sort of the findings from this study, one would hope that in subsequent years, when those national comparisons are done, that may not be the case.

Speaker 2:
[07:18] Yeah. Are other states looking at your success and implementing their own standards for PFAS?

Speaker 3:
[07:26] That's a great question. And that's something that we hope that other states can look to some of these successes. But I think the power of doing something like this and being able to publish these findings is that it can lead to exactly what you're describing. Best practices can be shared from states. These experiments that are done at a local level, you can test some of the kinks in the policy. Maybe it works well in certain contexts, but not others. Maybe it's addressing certain populations and not others. Those best practices can be shared to ultimately make drinking water safer for everybody.

Speaker 2:
[08:02] Dr. Iyer, I know you're a cancer researcher, and I'm wondering how you got interested in studying PFAS in drinking water.

Speaker 3:
[08:10] I've been studying prostate cancer since my doctoral training. One of the biological pathways that drives prostate cancer is sex hormone disruption. Endocrine disrupting chemicals have long been thought of as a potential risk factor. But there's been very few human epidemiologic studies that have robustly demonstrated this, have replicated in different populations. When I moved to New Jersey to start my job as an assistant professor here, one of the first things I did was talked to environmental health scientists at our university who have been studying not just forever chemicals but lead levels. I think it was really through conversations with them, learning more about the state, learning more about some of the health challenges that I became aware of it. And it seemed like it was a very important question, not just from a scientific side, but one that the residents of New Jersey are very concerned about.

Speaker 2:
[09:07] So what's next for your research here? I imagine since we don't know a lot about the long-term effects that you're interested in that.

Speaker 3:
[09:16] Yeah. So I think that the evidence right now has demonstrated a lot of these biomarkers, like we talked about liver enzymes and kidney function, and lipid levels and cholesterol levels are another area. But demonstrating these cancer pathways is incredibly difficult from a design perspective, because you have to follow people for many, many years and you have to get a really strong understanding of what their exposure was, not when you're talking to them today, but 10 years in the past. And so our lab is conducting a few studies right now, trying to reconstruct those historical PFAS levels by using some of the data that we presented in this study and developing predictive models, predicting the PFAS levels 15, 20 years ago in different parts of New Jersey. What we can do then is we can link those predictions to people's homes and where they may have moved over the course of their lives to be able to get a better measure of what that exposure may have been at a time when that cancer may have been developing.

Speaker 2:
[10:23] Whenever I think about PFAS or other carcinogens or potential carcinogens that we don't know about that take years to develop, I think about asbestos that we all sucked in for half a century from our car breaks and had no idea of how toxic it was. Could we be facing the same kind of thing with PFAS?

Speaker 3:
[10:48] Yeah, it's a really important point and with PFAS, I think it's also important when you think about this and put this in the historical context. When these chemicals were first used, they had a lot of really desirable properties. It's great to be able to fight fires. These plastic linings on the food that kept them preserved were important things at the time. I think with the story of PFAS and asbestos and some of these chemicals has shown, is that there's likely a balance that can be found in doing some evaluation of chemicals when they first come on the market where we don't fully understand what those long-term health outcomes are. But finding that balance, I think, is something that the PFAS story shows that we may have skewed too far on the side of technological progress. We'll worry about the problems later.

Speaker 2:
[11:42] Dr. Iyer, I want to thank you for taking time to be with us today.

Speaker 3:
[11:46] Thank you so much, Ira. It was great to speak with you.

Speaker 2:
[11:48] Good luck with your research. Dr. Hari Iyer, Assistant Professor of Cancer Epidemiology and Health Outcomes at the Rutgers Cancer Institute of New Jersey, based in New Brunswick. If you're listening and worried about PFAS in your drinking water, we have a list of resources on how to effectively filter out forever chemicals from your tap. Head to sciencefriday.com/pfas. That's sciencefriday.com/pfas. This episode was produced by Shoshana Buxbaum. Do you have a question you want us to look into? Please, our listener line is always open. Give us a call at 1-877-4-SciFri. 1-877-4-SciFri. I'm Ira Flatow. Thank you for listening.

Speaker 4:
[12:50] On Science Friday, we talk about the science, tech and health stories changing our world, from a pancreatic cancer vaccine, to data centers in space, to AI and art, to the real science behind cold plunges. We talk with world experts on issues listeners really care about. When you sponsor Science Friday, you connect with curious, engaged audiences who care deeply about discovery, innovation and evidence-based insight. To find out more about sponsorship opportunities visit sponsorship.wnyc.org.